Elsevier

Neurobiology of Disease

Volume 10, Issue 3, August 2002, Pages 258-267
Neurobiology of Disease

Regular Article
β-Amyloid Fragment 25–35 Causes Mitochondrial Dysfunction in Primary Cortical Neurons

https://doi.org/10.1006/nbdi.2002.0516Get rights and content

Abstract

β-Amyloid deposition and compromised energy metabolism both occur in vulnerable brain regions in Alzheimer's disease. It is not known whether β-amyloid is the cause of impairment of energy metabolism, nor whether impaired energy metabolism is specific to neurons. Our results, using primary neuronal cultures, show that 24-h incubation with Aβ25–35 caused a generalized decrease in the specific activity of mitochondrial enzymes per milligram of cellular protein, induced mitochondrial swelling, and decreased total mitochondrial number. Incubation with Aβ25–35 decreased ATP concentration to 58% of control in neurons and 71% of control in astrocytes. Levels of reduced glutathione were also lowered by Aβ25–35 in both neurons (from 5.1 to 2.9 nmol/mg protein) and astrocytes (from 25.2 to 14.9 nmol/mg protein). We conclude that 24-h treatment with extracellular Aβ25–35 causes mitochondrial dysfunction in both astrocytes and neurons, the latter being more seriously affected. In astrocytes mitochondrial impairment was confined to complex I inhibition, whereas in neurons a generalized loss of mitochondria was seen.

References (39)

  • R.F. Butterworth et al.

    Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease

    Metab. Brain Dis.

    (1990)
  • S.M. Cardoso et al.

    Functional mitochondria are required for amyloid beta-mediated neurotoxicity

    FASEB J.

    (2001)
  • C.S. Casley et al.

    Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities

    J. Neurochem.

    (2002)
  • K. Hirai et al.

    Mitochondrial abnormalities in Alzheimer's disease

    J. Neurosci.

    (2001)
  • V. Ibanez et al.

    Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease

    Neurology

    (1998)
  • J.N. Keller et al.

    Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: Role of the lipid peroxidation product 4-hydroxynonenal

    J. Neurochem.

    (1997)
  • T.S. King

    Preparation of succinate cytochrome c reductase, and the cytochrome b-cl particle, and reconstitution of succinate cytochrome c reductase

    Methods Enzymol.

    (1967)
  • S.J. Kish et al.

    Brain cytochrome oxidase in Alzheimer's disease

    J. Neurochem.

    (1992)
  • Y. Liu et al.

    Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis

    J. Neurochem.

    (1997)
  • Cited by (0)

    1

    Present address: Lilly Research Centre, Eli Lilly and Company, Erl Wood Manor, Sunninghill Rd., Windlesham, Surrey, GU20 6PH, UK.

    2

    To whom correspondence and reprint requests should be addressed. Fax: +44 20 7833 1016. E-mail: [email protected].

    View full text